Evidence map›Paper›PMID 21290211›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2011

Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.

Ja-Lok Ku, Kyung-Hee Kim, Jin-Sung Choi, You-Kyung Jeon, Sung-Hee Kim, Young-Kyoung Shin, Tae-You Kim, Yung-Jue Bang, Woo Ho Kim, Jae-Gahb Park

Open access · goldAbstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. The ethanol extract of Garcinia subelliptica Merr. induces autophagy.BMC complementary medicine and therapies · 2021
    Article
  2. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.Annals of oncology : official journal of the European Society for Medical Oncology · 2017
    Article
  3. EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2015
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ja-Lok KuKorean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea.
Kyung-Hee Kim
Jin-Sung Choi
You-Kyung Jeon
Sung-Hee Kim
Young-Kyoung Shin
Tae-You Kim
Yung-Jue Bang
Woo Ho Kim
Jae-Gahb Park
New Generation University College · ETSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSix human lung cancer cell lines (SNU-371, SNU-963, SNU-1327, SNU-1330, SNU-2292 and SNU-2315) were newly established through primary cell cultures. These cell lines were derived from a pulmonary blastoma, a small cell lung cancer, three adenocarcinomas and a squamous cell carcinoma of the lung of six Korean lung cancer patients.

methodsThe histopathology of the primary tumors and their in vitro growth characteristics were described. DNA fingerprinting analysis and genetic alterations in the p53, β-catenin, TGFβRII, K-ras and EGFR genes were conducted. mRNA expressions levels of E-cadherin, COX-2, MDR1, MXR, CGA, synatophysin and TTF1 genes were investigated and sensitivity to anticancer drugs was screened.

resultsFive cell lines grew as adherent cells and one cell line grew as floating aggregates. All lines were free of mycoplasma or bacteria and were proven unique by DNA fingerprinting analysis. A significant polymorphism at codon 72 (Arg to Pro) of the p53 gene was found in one line (SNU-1327) and a mutation at codon 176 was found in SNU-2292. No mutations in the K-ras, β-catenin and TGF-βRII genes were observed. E-cadherin was not expressed in SNU-371 and COX-2 was overexpressed in SNU-1330, SNU-2292 and SNU-2315 cell lines. MDR1 was overexpressed in SNU-371 and SNU-2292 cell lines and MXR was overexpressed in SNU-1327 cell line. Interestingly, the SNU-371 cell line derived from a pulmonary blastoma and which overexpressed MDR1 displayed cross resistance for several anticancer drugs. Neuroendocrine markers, chromogranin A and synaptophysin, were overexpressed in the small cell lung cancer cell line, SNU-963 and thyroid transcription factor-1 was also over expressed in this cell line. Two mutations (p.Glu746_Ser752delinsVal and p.Glu746_Ala750del) in exon 19 of EGFR were found in SNU-1330 and SNU-2315 cell lines, respectively.

conclusionThese well-characterized lung cancer cell lines may be useful tools for investigations of the biological characteristics of lung cancers, particularly for investigations related to mutations of EGFR.

Indexed as

Antineoplastic AgentsBase SequenceCell Line, TumorCell ShapeDNA FingerprintingDNA Mutational AnalysisDrug Screening Assays, AntitumorErbB ReceptorsGene Expression Regulation, NeoplasticGenes, NeoplasmGenetic LociHumansLung NeoplasmsMicrosatellite RepeatsMolecular Sequence DataMutationAntineoplastic AgentsErbB ReceptorsNeoplasm ProteinsTumor Suppressor Protein p53

Identifiers

PMID21290211
PMCPMC13014591
OpenAlexW2008369135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.